Transforming Mental Health With Botanically Inspired Neuromedicines

We’re developing a new class of precision pharmaceuticals that harness the therapeutic potential of DMT & Harmala Alkaloid combinations.

View Our Pipeline

The Problem

Despite decades of advances, existing mental health treatments remain narrowly focused on symptoms, and too often fail to deliver meaningful or enduring relief.

Our Mission

Our mission is to develop precision-targeted neuromedicines that engage key biological and psychological pathways to deliver transformative treatments for mental illness.

Our Approach

We're building on botanically inspired compounds to create a new class of precision, multi-target pharmaceuticals.

Neuroplasticity and Neuromodulation

Emotional Processing and Self-Insight

Increased Psychological Resilience

Our Science

We are applying novel science and advanced manufacturing methods to develop scalable DMT and harmala alkaloid medicines.

Our pharmaceutical-grade compounds are combined into proprietary formulations and dosage forms, optimised for clinical safety and therapeutic effect in each target indication.

Learn More

About Us

World Leading Expertise

Neurala’s founding team are global leaders in the development and clinical translation of DMT-harmala therapeutics, with more recent published work on these compounds than any other group in the world.

Learn More